+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Protein Assays - Global Strategic Business Report 2026

  • PDF Icon

    Report

  • 194 Pages
  • October 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 4805437
The global market for Protein Assays was valued at US$2.2 Billion in 2025 and is projected to reach US$5.1 Billion by 2032, growing at a CAGR of 12.8% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Protein Assays Market - Key Trends and Drivers Summarized

Analyzing the Potential: The Expanding Market for Protein Assays

Protein assays are fundamental tools in life sciences research, enabling the quantification and analysis of proteins in various biological samples. These assays are critical for understanding protein function, structure, and interactions, which are essential for developing new drugs, diagnostics, and therapies. The increasing focus on proteomics, the large-scale study of proteins, has significantly driven the demand for protein assays. In fields such as biotechnology, pharmaceuticals, and clinical diagnostics, protein assays are indispensable for quality control, drug discovery, and disease diagnosis. The growing prevalence of chronic diseases and the need for personalized medicine further underscore the importance of accurate and reliable protein assays in modern healthcare.

How Are Technological Advancements Influencing the Market?

Technological advancements have played a pivotal role in the evolution of protein assays. The development of high-throughput assays and automated systems has revolutionized the field, enabling the rapid and accurate quantification of proteins in complex biological samples. Innovations in fluorescence and luminescence-based assays have improved sensitivity and specificity, allowing researchers to detect low-abundance proteins with greater precision. The integration of microfluidics and lab-on-a-chip technologies has also enhanced the efficiency and scalability of protein assays, making them more accessible to researchers across various disciplines. Additionally, advancements in bioinformatics and data analysis tools have facilitated the interpretation of complex protein data, further driving the adoption of advanced protein assays in research and clinical settings.

What Are the Emerging Applications of Protein Assays?

Protein assays are increasingly being applied in emerging fields such as personalized medicine, biomarker discovery, and immunotherapy. In personalized medicine, protein assays are used to identify specific biomarkers that can guide the selection of targeted therapies for individual patients. The rise of immunotherapy, particularly in cancer treatment, has also driven the demand for protein assays that can assess the expression levels of immune checkpoint proteins, which are critical for determining the efficacy of these therapies. Additionally, protein assays are being used in the development of novel diagnostic tools, such as point-of-care tests, that provide rapid and accurate results at the patient’s bedside. These emerging applications are expanding the scope and utility of protein assays in both research and clinical practice.

What Are the Key Growth Drivers in the Market?

The growth in the protein assays market is driven by several factors. The increasing focus on proteomics and the need for advanced tools to study protein function and interactions are major drivers. Technological advancements, such as the development of high-throughput and automated assays, have significantly improved the efficiency and accuracy of protein quantification, driving their adoption in research and clinical settings. The growing prevalence of chronic diseases and the demand for personalized medicine have also spurred the need for reliable protein assays. Emerging applications, particularly in biomarker discovery and immunotherapy, are further expanding the market. Additionally, the integration of advanced data analysis tools and bioinformatics is enhancing the utility of protein assays, making them indispensable in modern life sciences research.

Report Scope

The report analyzes the Protein Assays market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Component (Kits Component, Reagents Component, Instruments & Accessories Component); Application (Drug Discovery & Development Application, Disease Diagnosis Application, Other Applications); End-Use (Pharma & Biotech Companies End-Use, Hospitals & Clinics End-Use, Other End-Uses).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Kits Component segment, which is expected to reach US$2.6 Billion by 2032 with a CAGR of a 14.6%. The Reagents Component segment is also set to grow at 10.3% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $644.3 Million in 2025, and China, forecasted to grow at an impressive 12.1% CAGR to reach $885.7 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Protein Assays Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Protein Assays Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Protein Assays Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abcam PLC, Bio-Rad Laboratories, Inc., Biovision Inc., Cell Signaling Technology, Inc., GE Healthcare Life Sciences and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Protein Assays market report include:

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Biovision Inc.
  • Cell Signaling Technology, Inc.
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • Lonza Group AG
  • Merck KgaA
  • Novus Biologicals LLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
  • An Overview of Protein Assays Market
  • Protein Assays - Global Key Competitors Percentage Market Share in 2026 (E)
  • A Prelude into Market Leading Players
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Increase in R&D Initiatives by Public and Private Companies is anticipated to Bolster Market Demand
  • Encouraging initiatives in Proteomics Research is Fuelling Worldwide Protein Assay Market
  • Rise in Biotech and Pharmaceutical R&D Expenditure Augurs Well for Market Growth
  • Global Pharmaceutical Industry: Breakdown of Total R&D Spend in USD Billion for years 2018, 2019, 2020, 2021, 2022
  • Increase in Cancer Prevalence: An Opportunity Indicator for Protein Assays Market
  • Increase in Technological Advancements to Fuel Growth in Protein Assay Market
  • Rising Demand in Biomedical research Propels Market Growth
  • Increasing Use in Drug Discovery and Development Expands Addressable Market Opportunity
  • Technological Advancements in Assay Sensitivity Strengthen Market Position
  • Growing Focus on Personalized Medicine Drives Adoption of Protein Assays
  • Surge in Demand for High-Throughput Screening Generates New Opportunities
  • Development of Multiplex Protein Assays Sustains Market Growth
  • Expanding Applications in Diagnostic Testing Throws Spotlight on Market Potential
  • Surge in Demand for Quantitative Proteomics Expands Market Horizons
  • Growing Awareness of Early Disease Detection Drives Market Adoption
  • Innovations in Microplate and Automated Assay Systems Generate New Market Opportunities
  • Rising Demand for Cost-Effective and Scalable Assay Solutions Throws Spotlight on Market Dynamics
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 2: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 3: World 13-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 4: World Protein Assays Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 5: World Recent Past, Current & Future Analysis for Protein Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Protein Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Protein Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Kits Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Kits Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Kits Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Reagents Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Reagents Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Reagents Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Instruments & Accessories Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Instruments & Accessories Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Instruments & Accessories Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Drug Discovery & Development Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Drug Discovery & Development Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Disease Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Disease Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Disease Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Protein Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abcam PLC
  • Bio-Rad Laboratories, Inc.
  • Biovision Inc.
  • Cell Signaling Technology, Inc.
  • GE Healthcare Life Sciences
  • Geno Technology Inc.
  • Lonza Group AG
  • Merck KgaA
  • Novus Biologicals LLC
  • PerkinElmer, Inc.
  • Promega Corporation
  • Thermo Fisher Scientific, Inc.

Table Information